Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators

BACKGROUND: Adequate response to the SARS-CoV-2 vaccine represents an important treatment goal in caring for patients with multiple sclerosis (MS) during the ongoing COVID-19 pandemic. Previous data so far have demonstrated lower spike-specific IgG responses following two SARS-CoV-2 vaccinations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatino, Joseph J., Mittl, Kristen, Rowles, William, Zamecnik, Colin R., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Alexander, Jessa, Mcpolin, Kira, Chen, PeiXi, Deshpande, Chinmay, Wyse, Kerri, Maiese, Eric M., Wilson, Michael R., Zamvil, Scott S., Bove, Riley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794398/
https://www.ncbi.nlm.nih.gov/pubmed/36608538
http://dx.doi.org/10.1016/j.msard.2022.104484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794398/
https://www.ncbi.nlm.nih.gov/pubmed/36608538
http://dx.doi.org/10.1016/j.msard.2022.104484

Ejemplares similares